Navigation Links
More Fake Avastin Found in U.S., FDA Says
Date:4/4/2012

WEDNESDAY, April 4 (HealthDay News) -- The U.S. Food and Drug Administration says it has confirmed another counterfeit version of the cancer drug bevacizumab, most commonly known as Avastin, is being sold in the United States.

This time, the counterfeit product -- which the FDA says contains no active ingredient -- is posing as injectable Altuzan (bevacizumab) 400 mg/16ml, a Roche cancer medication that is approved for use in Turkey but not in the United States.

"Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit," the FDA said in a statement released Wednesday.

According to the FDA, medical practices got the fake Altuzan from "foreign sources" that include Richards Pharma (aka Richards Services), Warwick Healthcare Solutions or Ban Dune Marketing Inc (BDMI).

"Many, if not all of the products sold and distributed through this distributor have not been approved by the FDA," the agency said. The agency is urging all medical practices that believe they have received unapproved products from the three companies to "stop using [the products] and contact the FDA."

This is not the first time counterfeit Avastin has been spotted in the United States. In mid-February, Roche's Genetech unit warned of fake vials of Avastin. Later that month, the company said the fake drug was probably not harmful, but did not contain any active ingredient and so would be useless for people fighting cancer.

Doctors infuse Avastin to treat colon, lung, kidney and brain cancer.

According to the Associated Press, worldwide reports of drug counterfeiting have increased over the past 10 years.

More information

There's more on bevacizumab at the U.S. National Cancer Institute.

-- E.J. Mundell

SOURCES: U.S. Food and Drug Administration, news release, April 4, 2012; Associated Press


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
2. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
3. FDA Advises Against Avastin as Treatment for Breast Cancer
4. More Evidence Links Avastin to Heart Failure in Breast Cancer Patients
5. More Evidence Cancer Drug Avastin May Cause Harm
6. NIH study finds Avastin and Lucentis are equally effective in treating AMD
7. Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
8. FDA Panel Rejects Avastin for Breast Cancer
9. Avastin Rejection Supported by Cancer Experts
10. Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients
11. FDA Revokes Approval of Avastin for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Fake  Avastin Found in U.S., FDA Says
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology: